Steroid Hormone Levels and Bone Mineral Density in Women over 65 years of Age

Overview

Journal Sci Rep

Specialty Science

Date 2023 Mar 25

PMID 36966199

Authors

Elsa Nunes

Eugenia Gallardo

Sara Morgado-Nunes

Jose Fonseca-Moutinho

Affiliations

Soon will be listed here.

Abstract

Previous studies using immunoassays for steroid measurements have focused on the association between steroid hormone levels and bone mineral density (BMD) in postmenopausal women, obtaining contradictory results. This study aimed to assess this association using a highly sensitive bioanalytical method. A total of 68 postmenopausal women, aged 65-89 years, were enrolled in a cross-sectional study. Measurements of the BMD of the hip and lumbar spine were performed using dual energy X-ray absorptiometry, and serum hormone levels were quantified by gas chromatography and tandem mass spectrometry. Associations between estradiol (E2), testosterone, dehydroepiandrosterone (DHEA), androstenedione and T score levels of the hip and lumbar spine were evaluated, after adjustment for confounding variables. The analysis revealed a statistically significant association between testosterone and the T score of the hip (p = 0.035), but not that of the lumbar spine. No statistically significant associations were found between E2, DHEA, androstenedione and the T scores of the hip and the lumbar spine. Using a highly sensitive hormone assay method, our study identified a significant association between testosterone and BMD of the hip in women over 65 years of age, suggesting that lower testosterone increases the risk of osteoporosis.

Citing Articles

The association between sex hormones and bone mineral density in US females.

Tian X, Zhang B Sci Rep. 2025; 15(1):5546.

PMID: 39953073 PMC: 11829004. DOI: 10.1038/s41598-025-89985-z.

The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence.

Bushell A, Crespi B Front Reprod Health. 2024; 6:1475132.

PMID: 39403367 PMC: 11471738. DOI: 10.3389/frph.2024.1475132.

Predictive value of serum inflammatory biomarkers in postmenopausal osteoporosis: A cross-sectional study in northwest Iran.

Sarrafi S, Vahedi L, Pourzainali S, Ranjbar M, Farshbaf-Khalili A, Babaie S Heliyon. 2024; 10(17):e36247.

PMID: 39263180 PMC: 11386009. DOI: 10.1016/j.heliyon.2024.e36247.

Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes.

Li S, Li W, Chang L, Wan J, Chen S, Zhang X J Bone Miner Metab. 2024; 42(3):361-371.

PMID: 38769209 DOI: 10.1007/s00774-024-01511-9.

Androgen deficiency in hypopituitary women: its consequences and management.

Esposito D, Tivesten A, Olivius C, Ragnarsson O, Johannsson G Rev Endocr Metab Disord. 2024; 25(3):479-488.

PMID: 38240912 PMC: 11162366. DOI: 10.1007/s11154-024-09873-1.

References

Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M . Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021; 16(1):669. PMC: 8590304. DOI: 10.1186/s13018-021-02821-8. View

Caron P, Turcotte V, Guillemette C . A chromatography/tandem mass spectrometry method for the simultaneous profiling of ten endogenous steroids, including progesterone, adrenal precursors, androgens and estrogens, using low serum volume. Steroids. 2015; 104:16-24. DOI: 10.1016/j.steroids.2015.07.009. View

Handelsman D, Wartofsky L . Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab. 2013; 98(10):3971-3. DOI: 10.1210/jc.2013-3375. View

Melton 3rd L, Khosla S, Malkasian G, Achenbach S, Oberg A, Riggs B . Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res. 2003; 18(5):900-5. DOI: 10.1359/jbmr.2003.18.5.900. View

French D . Advances in bioanalytical techniques to measure steroid hormones in serum. Bioanalysis. 2016; 8(11):1203-19. DOI: 10.4155/bio-2015-0025. View

Vermeulen A . The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 1976; 42(2):247-53. DOI: 10.1210/jcem-42-2-247. View

Jankowski C, Wolfe P, Schmiege S, Nair K, Khosla S, Jensen M . Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials. Clin Endocrinol (Oxf). 2018; 90(2):293-300. PMC: 6336516. DOI: 10.1111/cen.13901. View

Slemenda C, Longcope C, Peacock M, Hui S, JOHNSTON C . Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest. 1996; 97(1):14-21. PMC: 507057. DOI: 10.1172/JCI118382. View

Rariy C, Ratcliffe S, Weinstein R, Bhasin S, Blackman M, Cauley J . Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study. J Clin Endocrinol Metab. 2011; 96(4):989-96. PMC: 3070250. DOI: 10.1210/jc.2010-0926. View

10.

Zofkova I, Bahbouh R, Hill M . The pathophysiological implications of circulating androgens on bone mineral density in a normal female population. Steroids. 2000; 65(12):857-61. DOI: 10.1016/s0039-128x(00)00136-7. View

11.

Davis S, McCloud P, Strauss B, Burger H . Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 2009; 61(1-2):17-26. DOI: 10.1016/j.maturitas.2008.09.006. View

12.

Murphy S, Khaw K, Sneyd M, Compston J . Endogenous sex hormones and bone mineral density among community-based postmenopausal women. Postgrad Med J. 1992; 68(805):908-13. PMC: 2399470. DOI: 10.1136/pgmj.68.805.908. View

13.

Maroulis G, ABRAHAM G . Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women. Obstet Gynecol. 1976; 48(2):150-4. View

14.

McDonald J, Matthew S, Auchus R . Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseases. Horm Cancer. 2011; 2(6):324-32. PMC: 3437926. DOI: 10.1007/s12672-011-0099-x. View

15.

Couzinet B, Meduri G, Lecce M, Young J, Brailly S, Loosfelt H . The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab. 2001; 86(10):5060-6. DOI: 10.1210/jcem.86.10.7900. View

16.

Labrie F, Martel C, Belanger A, Pelletier G . Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. J Steroid Biochem Mol Biol. 2017; 168:9-18. DOI: 10.1016/j.jsbmb.2016.12.007. View

17.

Tok E, Ertunc D, Oz U, Camdeviren H, Ozdemir G, Dilek S . The effect of circulating androgens on bone mineral density in postmenopausal women. Maturitas. 2004; 48(3):235-42. DOI: 10.1016/j.maturitas.2003.11.007. View

18.

Lambrinoudaki I, Christodoulakos G, Aravantinos L, Antoniou A, Rizos D, Chondros C . Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women. J Bone Miner Metab. 2005; 24(1):65-71. DOI: 10.1007/s00774-005-0648-x. View

19.

Ghebre M, Hart D, Hakim A, Kato B, Thompson V, Arden N . Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study. Calcif Tissue Int. 2011; 89(4):295-302. PMC: 3175043. DOI: 10.1007/s00223-011-9518-9. View

20.

Judd H, JUDD G, Lucas W, Yen S . Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974; 39(6):1020-4. DOI: 10.1210/jcem-39-6-1020. View